Status:
UNKNOWN
A Study on the Outcome and Its Influencing Factors in Patients With Borderline Personality Disorder
Lead Sponsor:
Wuhan Mental Health Centre
Conditions:
Borderline Personality Disorder
Eligibility:
All Genders
12+ years
Brief Summary
Borderline personality disorder (BPD) is a difficult chronic mental illness. This diagnosis is common in Western countries. Our researchers want to study the outcome and its influencing factors of BPD...
Detailed Description
This study is an ambispective cohort study. The information collected in the retrospective part mainly included demographic data, comorbid psychiatric diagnosis, psychotherapeutive and pharmacotherape...
Eligibility Criteria
Inclusion
- Diagnosis of BPD based on ICD-10 (F60.3)
Exclusion
- Comorbidity with severe physical disease
- Comorbidity with neurological diseases such as epilepsy
- Comorbidity with mental retardation
Key Trial Info
Start Date :
October 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT06005779
Start Date
October 22 2021
End Date
September 1 2024
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan Mental Health Centre
Wuhan, Hubei, China, 430014